Trending

AAPL

AMZN

$124.25 $1.48 1.21%

TSLA

$213.97 $6.45 3.11%

GOOG

$125.23 $0.86 0.69%

Market Movers, Stocks

(NASDAQ:HGEN) shares are trading higher on positive financial results. Biotechnology is still a hot sector.

by 24/7 MarketNews Admin

May 6, 2022 at 12:10 PM

Humanigen Reports First Quarter 2022 Financial Results

SHORT HILLS, N.J.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate, lenzilumab (LENZ), today provided a corporate update and reported financial results for the first quarter ended March 31, 2022.

Read the entire artilcle: https://www.businesswire.com/news/home/20220505005996/en/Humanigen-Reports-First-Quarter-2022-Financial-Results

RelatedNews

MultiMetaVerse Plans to Acquire Equity Stake in Taomee

Janssen to Move forward with Clinical Development of LAVA Therapeutics’s Lead Gamma-Delta T-Cell Engager Bispecific Antibody

Autolus Therapeutics to Present Positive Results from its Phase 2 FELIX study in adult r/r B-ALL at ASCO

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data

Monopar Reports Positive Camsirubicin Phase 1b Trial Update

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MultiMetaVerse Plans to Acquire Equity Stake in Taomee

June 2, 2023

Janssen to Move forward with Clinical Development of LAVA Therapeutics’s Lead Gamma-Delta T-Cell Engager Bispecific Antibody

June 2, 2023

Autolus Therapeutics to Present Positive Results from its Phase 2 FELIX study in adult r/r B-ALL at ASCO

June 2, 2023

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data

June 2, 2023

Monopar Reports Positive Camsirubicin Phase 1b Trial Update

June 1, 2023

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

(NASDAQ:HGEN) shares are trading higher on positive financial results. Biotechnology is still a hot sector.

Humanigen Reports First Quarter 2022 Financial Results

RelatedNews

MultiMetaVerse Plans to Acquire Equity Stake in Taomee

Janssen to Move forward with Clinical Development of LAVA Therapeutics’s Lead Gamma-Delta T-Cell Engager Bispecific Antibody

Autolus Therapeutics to Present Positive Results from its Phase 2 FELIX study in adult r/r B-ALL at ASCO

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data

Monopar Reports Positive Camsirubicin Phase 1b Trial Update

Want more news like this? Check out our homepage!

Recent News

MultiMetaVerse Plans to Acquire Equity Stake in Taomee

Janssen to Move forward with Clinical Development of LAVA Therapeutics’s Lead Gamma-Delta T-Cell Engager Bispecific Antibody

Autolus Therapeutics to Present Positive Results from its Phase 2 FELIX study in adult r/r B-ALL at ASCO

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data

Monopar Reports Positive Camsirubicin Phase 1b Trial Update

Follow Us

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Search by keyword

Add New Playlist